Provided By GlobeNewswire
Last update: May 13, 2025
Data also demonstrate significantly lower rates of postoperative reflux and decreased incidence of de novo gastroesophageal reflux disease (GERD) without affecting total weight loss at 1-year*, and shorter average hospital length of stay (LOS) associated with use of the Titan SGS™ Stapler compared with multi-fire staplers1
Read more at globenewswire.comNYSE:TFX (6/18/2025, 9:52:25 AM)
117.21
-0.32 (-0.27%)
Find more stocks in the Stock Screener